A Study In Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 2006-10-31
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• A clinical diagnosis type 2 diabetes mellitus.

• Women must not be pregnant or breastfeeding during the study and 30 days after the study.

• Must sign an informed consent form at the study clinic.

Exclusion criteria:

• Severe chronic diseases that would prevent from participating and completing the study by investigator's judgement.

• Use of an investigational drug within 30 days or 5 half lives before first dose of study medication.

• Insulin use for > 1 week in past 3 months.